B-Lymphocytes

Immune cell multiomics analysis reveals contribution of oxidative phosphorylation to B-cell functions and organ damage of lupus
Yusuke Takeshima, Yukiko Iwasaki, Masahiro Nakano, Yuta Narushima, Mineto Ota, Yasuo Nagafuchi, Shuji Sumitomo, Tomohisa Okamura, Keith Elkon, Kazuyoshi Ishigaki, Akari Suzuki, Yuta Kochi, Kazuhiko Yamamoto, Keishi Fujio

Annals of the Rheumatic Diseases Jun 2022, 81 (6) 845-853; DOI: 10.1136/annrheumdis-2021-221464
Biological impact of iberdomide in patients with active systemic lupus erythematosus
Peter E Lipsky, Ronald van Vollenhoven, Thomas Dörner, Victoria P Werth, Joan T Merrill, Richard Furie, Milan Petronijevic, Benito Velasco Zamora, Maria Majdan, Fedra Irazoque-Palazuelos, Robert Terbrueggen, Nikolay Delev, Michael Weiswasser, Shimon Korish, Mark Stern, Sarah Hersey, Ying Ye, Allison Gaudy, Zhaohui Liu, Robert Gagnon, Shaojun Tang, Peter H Schafer

Annals of the Rheumatic Diseases Apr 2022, annrheumdis-2022-222212; DOI: 10.1136/annrheumdis-2022-222212
Proteogenomic analysis of the autoreactive B cell repertoire in blood and tissues of patients with Sjögren’s syndrome
Mathijs G A Broeren, Jing J Wang, Giulia Balzaretti, Patricia J T A Groenen, Barbera D C van Schaik, Tim Chataway, Charlotte Kaffa, Sander Bervoets, Konnie M Hebeda, Gergana Bounova, Ger J M Pruijn, Thomas P Gordon, Niek De Vries, Rogier M Thurlings

Annals of the Rheumatic Diseases May 2022, 81 (5) 644-652; DOI: 10.1136/annrheumdis-2021-221604
From sequential to combination and personalised therapy in lupus nephritis: moving towards a paradigm shift?
Ioannis Parodis, Frederic A Houssiau

Annals of the Rheumatic Diseases Jan 2022, 81 (1) 15-19; DOI: 10.1136/annrheumdis-2021-221270
B cell depletion impairs vaccination-induced CD8⁺ T cell responses in a type I interferon-dependent manner
Theresa Graalmann, Katharina Borst, Himanshu Manchanda, Lea Vaas, Matthias Bruhn, Lukas Graalmann, Mario Koster, Murielle Verboom, Michael Hallensleben, Carlos Alberto Guzmán, Gerd Sutter, Reinhold E Schmidt, Torsten Witte, Ulrich Kalinke

Annals of the Rheumatic Diseases Dec 2021, 80 (12) 1537-1544; DOI: 10.1136/annrheumdis-2021-220435
Response to: ‘Correspondence on ‘Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis’’ by Parikh et al
Rona M Smith, Peter A Merkel, David Jayne

Annals of the Rheumatic Diseases Feb 2021, annrheumdis-2020-219329; DOI: 10.1136/annrheumdis-2020-219329
Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression
Maria Prendecki, Candice Clarke, Helena Edwards, Stacey McIntyre, Paige Mortimer, Sarah Gleeson, Paul Martin, Tina Thomson, Paul Randell, Anand Shah, Aran Singanayagam, Liz Lightstone, Alison Cox, Peter Kelleher, Michelle Willicombe, Stephen P McAdoo

Annals of the Rheumatic Diseases Oct 2021, 80 (10) 1322-1329; DOI: 10.1136/annrheumdis-2021-220626
SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response
Michael Markus Bonelli, Daniel Mrak, Thomas Perkmann, Helmuth Haslacher, Daniel Aletaha

Annals of the Rheumatic Diseases Oct 2021, 80 (10) 1355-1356; DOI: 10.1136/annrheumdis-2021-220408
Correspondence on ‘Immunogenicity and safety of anti-SARS-Cov-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort’
Chiara Salviani, Francesco Scolari, Federico Alberici

Annals of the Rheumatic Diseases Oct 2021, 80 (10) e158; DOI: 10.1136/annrheumdis-2021-220496
Response to: Correspondence on “SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response” by Bonelli et al
Michael Bonelli, Daniel Aletaha

Annals of the Rheumatic Diseases Oct 2021, 80 (10) e167; DOI: 10.1136/annrheumdis-2021-220997

Main menu

B-Lymphocytes

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

B-Lymphocytes

Pages